Abstract

IntroductionEQ-5D is an instrument which has been utilized for a variety of purposes, including in health-economic appraisals as an input into quality-adjusted life year (QALY) calculations. Indeed, it is the most-widely applied instrument for health-economic appraisal worldwide, and is recommended for use in QALY calculations by many national Health Technology Assessment (HTA) agencies. There is also a growing body of evidence for its usefulness in a variety of settings other than economic appraisals, but such use has not been well-documented. This study addresses this issue and documents how EQ-5D has been applied in both the non-economic and economic contexts.MethodsThe PubMed database was searched using the terms ‘EQ-5D’, ‘EQ-5D AND cost’, and ‘EQ-5D AND cost AND QALY’ from 1 January 1980 to 31 December 2019. We concentrated on 2019 publications for more detailed analyses. All the data collected for 2019 were downloaded and collected in EndNote. For 2019 only, we classified economic and non-economic use based on the inclusion of ‘cost’. We also checked by manual inspection whether the search terms were suitable in correctly identifying economic and non-economic use. Variants of the non-economic use of EQ-5D were classified as follows: (a) as a quality of life outcome measure; (b) as a tool for methodological research; (c) methodological issues of EQ-5D itself; (d) comparisons with other quality of life questionnaires; (e) mapping studies; (f) value sets; (g) alongside costs but no QALY calculated; and (h) other.ResultsThe first publication found was from 1990. Up to and including 2019, 10,817 publications were identified, of which more than two in three did not contain any reference to costs or QALYs. In 2019, a total of 1409 manuscripts were identified, of which 239 were specifically for EQ-5D-5L. Four hundred and seven (28.9%) included some form of ‘costs’ and 157 (11.1%) both ‘costs’ AND ‘QALYs’ terms. For EQ-5D-5L, the corresponding numbers were 104 (43.5%) and 29 (12.1%), respectively. After manually checking all the 1409 papers, three were duplicated records, which were omitted. In the remaining 1406 papers, only 40 (2.8%) contained the term ‘cost’, but not ‘cost per QALY’, and only 117 (8.3%) were identifiable as economic evaluations using the term ‘cost per QALY’. Most non-economic use of EQ-5D was as a quality-of-life outcome measure (72.8%). Other applications were: as a tool for methodological research (6.7%); comparison studies (3.7%); EQ-5D methodological issues (3.5%); containing costs but not QALYs (2.8%); mapping (1.3%); value sets (0.4%); and other papers (0.4%).ConclusionsThe majority of the studies retrieved, covering a wide variety of research areas, reported upon the non-economic use of EQ-5D. Despite being the most-used instrument worldwide for QALY calculations, economic appraisal accounted for only a small, but important, part of published use.

Highlights

  • EQ-5D is an instrument which has been utilized for a variety of purposes, including in health-economic appraisals as an input into quality-adjusted life year (QALY) calculations

  • In a recent review of official national pharmacoeconomic guidelines, it was concluded that EQ-5D was, by far, the most frequently recommended instrument: in 85% of the guidelines, EQ-5D was either the preferred instrument to measure health-related quality-of-life (HRQoL) or as an example instrument utilized in cost–utility analysis [4]

  • Articles published in the final year of the time frame employed were studied in detail: we manually examined the title and abstract of all publications identified in 2019, to investigate the non-economic use of EQ-5D

Read more

Summary

Introduction

EQ-5D is an instrument which has been utilized for a variety of purposes, including in health-economic appraisals as an input into quality-adjusted life year (QALY) calculations. The EQ-5D instrument is a health-related quality-of-life (HRQoL) questionnaire which has been extensively used for a variety of purposes around the world [1], including a wide range of clinical studies, randomized controlled trials, and population health surveys. In a recent review of official national pharmacoeconomic guidelines, it was concluded that EQ-5D was, by far, the most frequently recommended instrument: in 85% of the guidelines, EQ-5D was either the preferred instrument to measure HRQoL or as an example instrument utilized in cost–utility analysis [4] While this is evidence of the successful uptake of EQ-5D in the context of economic evaluation, there is a lack of knowledge regarding its use for a wide variety of other purposes. This paper: (i) calculates the relative use of EQ-5D in non-economic and health economic studies and (ii) describes and applies a classification system for the analysis of EQ-5D-related studies

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call